Results 131 to 140 of about 58,249 (234)

Activity of ceftazidime-avibactam combinations against carbapenem-resistant Klebsiella pneumoniae assessed by checkerboard method

: The aim of this study is to detect the carbapenemase type and to determine the in vitro effects of ceftazidime/avibactam-colistin, ceftazidime/avibactam-meropenem and ceftazidime/avibactam-tigecycline combinations against Carbapenem-Resistant ...
Ayten Nur Uzun, Uzun, Ayten Nur, Hilal Tanriverdi, Tanriverdi, Hilal, GENÇ, SERPİL, Serpil Genç   +5 more
core   +1 more source

Publication Only

HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Failure of endophthalmitis prophylaxis: laboratory model comparing antibiotics and bacterial loads. [PDF]

J Cataract Refract Surg
Moon M, Mathews S, Mahjabin F, Karaiskos K, Libre PE.   +4 more
europepmc   +1 more source

The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection

, 1995
Isepamicin is a new aminoglycoside antibiotic which has a superior stability to aminoglycoside-inactivating enzymes compared with other available aminoglycosides.
Colardyn, Francis
core  

Evaluating the efficacy of ceftazidime/avibactam plus amikacin combination therapy as a carbapenem-sparing agent against ceftazidime/avibactam-resistant <i>Escherichia coli</i> using a hollow fiber infection model: a proof-of-concept study. [PDF]

Antimicrob Agents Chemother
Walker MM, Roberts JA, Li Y, Naicker S, Wallis SC, Ordonez JL, Won H, Forde BM, Sime FB.   +8 more
europepmc   +1 more source

<i>In vitro</i> activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in Japan. [PDF]

JAC Antimicrob Resist
Yanagihara K, Tateda K, Doi Y, Takahashi S, Ohge H, Itahashi K, Okade H, Mikamo H.   +7 more
europepmc   +1 more source

Corrigendum: Reactive Oxygen Species-Related Ceftazidime Resistance Is Caused by the Pyruvate Cycle Perturbation and Reverted by Fe3+ in Edwardsiella tarda

Frontiers in Microbiology, 2021
Jinzhou Ye, Yubin Su, Xuanxian Peng, Xuanxian Peng, Hui Li, Hui Li   +5 more
doaj   +1 more source

Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella Pneumoniae Infection: A Retrospective, Single Center Study

Chen-Huan Yu,1 Mao-Song Tsai,2 Chun-Hsing Liao,2 Chia-Jui Yang2 1Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan; 2Division of Infectious Disease, Department of Internal Medicine, Far Eastern Memorial Hospital, New
Tsai MS, Yu CH, Yang CJ, Liao CH
core  

Combination Therapy with Ceftazidime-Avibactam, Aztreonam, and Topical Polymyxin B for NDM-Producing <i>Klebsiella pneumoniae</i> CNS Infection: A Case Report. [PDF]

Infect Drug Resist
Qi G, Cong W, Zhang M, Wang S, Bai Z, Li B, Chen H.   +6 more
europepmc   +1 more source

Mutational basis of ceftazidime-borrelidin A collateral sensitivity in Escherichia coli. [PDF]

G3 (Bethesda)
Phillips LL, Carrasco A, Weiss J, Liu DY, Linington RG, Wong A.   +5 more
europepmc   +1 more source